Preliminary definition of disease flare in juvenile rheumatoid arthritis.
Explore this paper's citation graph
Summary
CRV are useful for defining flare in JRA and worsening in any 2/6 CRV without concomitant improvement of more than one of the remaining CRV by > or = 30% appears to be the most suitable preliminary flare definition.
- Type
- article
- Published
- 2002-05-01
- Cited by
- 134
- References
- 0
- OpenAlex
- https://openalex.org/W1903167817
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:12300030
Keywords
Medicine, Flare, Juvenile rheumatoid arthritis, Erythrocyte sedimentation rate, Concomitant
References
No references recorded for this paper.
Cited by
- Salivary Antioxidants and Metalloproteinases in Juvenile Idiopathic Arthritis
- Anti-TNF treatment in juvenile idiopathic arthritis and associated uveitis : Clinical perspectives on growth, uveitis, and drug survival
- АБАТАЦЕПТ: НОВЫЕ ВОЗМОЖНОСТИ В ТЕРАПИИ ДЕТЕЙ С ПОЛИАРТИКУЛЯРНЫМ ЮВЕНИЛЬНЫМ ИДИОПАТИЧЕСКИМ АРТРИТОМ
- The development and assessment of biological treatments for children.
- Efficacy and Safety of Etanercept in Patients With the Enthesitis‐Related Arthritis Category of Juvenile Idiopathic Arthritis: Results From a Phase III Randomized, Double‐Blind Study
- Juvenile Idiopathic Arthritis
- Mechanisms of disease and therapy in severe juvenile idiopathic arthritis
- Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA)
- Salivary gland involvement and oxidative stress in juvenile idiopathic arthritis: novel observation in oligoarticular-type patients.
- Artritis idiopàtica juvenil. Revisió i nous conceptes
- Possible role of streptococcal infection in flares of juvenile idiopathic arthritis.
- CD23+/CD21hi B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice
- Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
- Outcomes Research in Childhood Autoimmune Diseases
- Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study
- Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
- Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids
- Canakinumab for the treatment of systemic juvenile idiopathic arthritis
- Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician.
- A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.
Related papers
- 90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis
- Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis.
- Etanercept treatment for children with refractory juvenile idiopathic arthritis.
- Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period
- A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study
- Juvenile idiopathic arthritis coexisting with sickle cell disease: two case reports
- Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis.
- FRI0344 Safety and efficacy of etanercept in juvenile idiopathic arthritis patients under two years of age
- AB0249 Investigating the effect of etanercept on the peripheral B cell compartment in children with juvenile idiopathic arthritis
- Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register